| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10919734 | Radiotherapy and Oncology | 2011 | 5 Pages |
Abstract
These studies revealed that the greater anti-proliferative effects and increased cytotoxicity of cetuximab in the STAT3-2.4 and STAT3-2.9 cells compared to control NEG4.17 cells, may be a result of STAT3-mediated effects on cellular apoptosis and DNA damage.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
James A. Bonner, Eddy S. Yang, Hoa Q. Trummell, Somaira Nowsheen, Christopher D. Willey, Kevin P. Raisch,